Familial autoimmunity and polyautoimmunity in 60 Brazilian Midwest patients with systemic sclerosis;Autoimunidade familial e poliautoimunidade em 60 pacientes portadores de esclerose sistêmica da região Centro-Oeste do Brasil

Revista Brasileira de Reumatologia

Volumn 56, Issue 4, 2016, Pages 314-322

  Horimoto, Alex Magno Coelho ^a,b   Silveira, Aida Freitas do Carmo ^a   da Costa, Izaias Pereira ^a,c  

^a FEDERAL UNIVERSITY OF MATO GROSSO DO SUL   (Brazil)

^b Hospital Regional de Mato Grosso do Sul   (Brazil)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Autoantibodies; Autoimmune disease; Familial autoimmunity; Poliautoimmunity; Systemic sclerosis

Indexed keywords

ARTICLE; AUTOIMMUNE DISEASE; BRAZILIAN; COMORBIDITY; CROSS-SECTIONAL STUDY; DISEASE ACTIVITY; DISEASE SEVERITY; HASHIMOTO DISEASE; HUMAN; MAJOR CLINICAL STUDY; MYOSITIS; PREVALENCE; RHEUMATOID ARTHRITIS; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS; AUTOIMMUNE THYROIDITIS; AUTOIMMUNITY; BRAZIL; COMPLICATION; IMMUNOLOGY;

AUTOANTIBODY;

ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; AUTOIMMUNITY; BRAZIL; CROSS-SECTIONAL STUDIES; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; SCLERODERMA, SYSTEMIC; SJOGREN'S SYNDROME; THYROIDITIS, AUTOIMMUNE;

EID: 85011284385     PISSN: 04825004     EISSN: 18094570     Source Type: Journal    
DOI: 10.1016/j.rbre.2016.01.003     Document Type: Article

References (50)

1. Varga J., Abraham D. Systemic sclerosis: a prototypic multisystem fibrotic disorder. J Clin Invest 2007, 117(3):557-567.
2. Herrick A.L., Worthington J. Genetic epidemiology Systemic sclerosis. Arthritis Res 2002, 4(3):165-168.
3. Geyer M., Müller-Ladner U. The pathogenesis of systemic sclerosis revisited. Clinic Rev Allerg Immunol 2011, 40:92-103.
4. Meda F., Folci M., Baccarelli A., Selmi C. The epigenetics of autoimmunity. Cell Mol Immunol 2011, 8(3):226-236.
5. Briggs D., Welsh K.I. Major histocompatibility complex class II genes and systemic sclerosis. Ann Rheum Dis 1991, 50:862-865.
6. Rees R.B., Bennett J. Localized scleroderma in father and daughter. AMA Arch Derm Syphilol 1953, 68(3):360.
7. Barnett A.J., McNeilage L.J. Antinuclear antibodies in patients with scleroderma (systemic sclerosis) and in their blood relatives and spouses. Ann Rheum Dis 1993, 52:365-368.
8. Mayers M.D., Trojanowska M. Genetic factors in systemic sclerosis. Arthritis Res Ther 2007, 9(Suppl 2):S5.
9. Romano E., Manetti M., Guiducci S., Ceccarelli C., Allanore Y., Matucci-Cerinic M. The genetics of systemic sclerosis: an update. Clin Exp Rheumatol 2011, 29(65):S75-S86.
10. Arora-Singh R.K., Assassi S., Junco D.J., Arnett F.C., Perry M., Irfan U., et al. Autoimmune diseases and autoantibodies in the first degree relatives of patients with systemic sclerosis. J Autoimmun 2010, 35(1):52-57.
11. Anaya J.M., Gómez L.M., Castiblanco J. Is there a common genetic basis for autoimmune diseases?. Clin Dev Immunol 2006, 13(2-4):185-195.
12. Hudson M., Rojas-Villarraga A., Coral-Alvarado P., López-Guzmán S., Mantilla R.D., Chalem P., et al. Polyautoimmunity and familial autoimmunity in systemic sclerosis. J Autoimm 2008, 31:156-159.
13. Hoogen F., Khanna D., Fransen J., Johnson S.R., Baron M., Tyndall A., et al. 2013 classification criteria for systemic sclerosis: an American college of rhematology/European league against rheumatism collaborative initiative. Ann Rheum Dis 2013, 72:1747-1755.
14. LeRoy E.C., Medsger T.A. Criteria for the Classification of Early Systemic Sclerosis. J Rheumatol 2001, 28(7):1573-1576.
15. Petri M., Orbai A.M., Alarcón G.S., Gordon C., Merrill J.T., Fortin P.R., et al. Derivation and validation of the Systemic Lupus International Collaborating Clinics Classification Criteria for Systemic Lupus Erythematosus. Arthritis Rheum 2012, 64(8):2677-2686.
16. Shiboski S.C., Shiboski L.H., Criswell L.A., Baer A.N., Challacombe S., Lanfranchi H., et al. American College of Rheumatology Classification Criteria for Sjögren's Syndrome: A data-driven, expert consensus approach in the Sjögren's International Collaborative Clinical Alliance Cohort. Arthritis Care Res 2012, 64(4):475-487.
17. Aletaha D., Neogi T., Silman A.J., Funovits J., Felson D.T., Bingham C.O., et al. 2010 Rheumatoid Arthritis classification criteria. An American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum 2010, 62(9):2569-2581.
18. Sampaio S.A.P., Rivitti E.A. Dermatologia 2007, 231-256. Artes Médicas, São Paulo. 3 ed.
19. Rudwaleit M., van der Heijde D., Landewé R., Akkoc N., Brandt J., Chou C.T., et al. The Assessment of SpondyloArthritis International Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general. Ann Rheum Dis 2011, 70(1):25-31.
20. Hanauer S.B., Sandborn W. The Practice Parameters Committee of The American College of Gastroenterology. Management of Crohn's Disease in Adults. Am J Gastroenterol 2001, 96:635-643.
21. Miyakis S., Lockshin M.D., Atsumi T., Branch D.W., Brey R.L., Cervera R., et al. International consensus statement on an update to the classification for definite antiphospholipid syndrome (APS). J Thromb Haemost. 2006, 4:295-306.
22. De Groot L.J., Larsen P.R., Henneman G. Hashimoto's thyroiditis: The thyroid and it's diseases 1996, 307-322. Churchill Livingstone, New York. 6 ed.
23. American Diabetes Association. Standards of Medical Care in Diabetes. Diabetes Care 2010, 33:11-61.
24. Alarcon-Segovia D., Cardiel M.H. Comparison between 3 diagnostic criteria for mixed connective tissue disease. Study of 593 patients. J Rheumatol 1989, 16:328-334.
25. Bohan A., Peter J.B. Polymyositis and dermatomyositis (first of two parts). N Engl J Med 1975, 292:344-347.
26. Valentini G., D'Angelo S., Rossa A.D., Bencivelli W., Bombardieri S. European Scleroderma Study Group to define disease activity criteria for systemic sclerosis. IV. Assessment of skin thickening by modified Rodnan skin score. Ann Rheum Dis 2003, 62:904-905.
27. Medsger T.A. Natural history of systemic sclerosis and the assessment of disease activity, severity, functional status, and psychologic well-being. Rheum Dis Clin N Am 2003, 29:255-273.
28. Valentini G., Silman A.J., Veale D. Assessment of disease activity. Clin Exp Rheumatol 2003, 21:39-41.
29. Rannou F., Poiraudeau S., Berezné A., Baubet T., Le-Guern V., Cabane J., et al. Assessing disability and quality of life in systemic sclerosis: construct validities of the Cochin hand function scale, health assessment questionnaire (HAQ), systemic sclerosis HAQ, and medical outcomes study 36-item short form health survey. Arthritis Rheum 2007, 57(1):94-102.
30. Dellavance A., Gabriel A., Cintra A.F.U., Ximenes A.C., Nuccitelli B., Tabilerti B.H., et al. II Consenso Brasileiro de Fator Antinuclear em células Hep-2. Rev Bras Reumatol 2003, 43(3):129-140.
31. McClain M.T., Ramsland P.A., Kaufman K.M. Anti-Sm autoantibodies in systemic lupus target highly basic surface structures of complexed spliceosomal autoantigens. J Immunol 2002, 168:2054-2062.
32. Sato S., Hamaguchi Y., Hasegawa M., Takehara K. Clinical significance of anti-topoisomerase I antibody levels determined by ELISA in systemic sclerosis. Rheum 2001, 40:1135-1140.
33. Codullo V., Morozzi G., Bardoni A., Salvini R., Deleonardi G., Pità O., et al. Validation of a new immunoenzymatic method to detect antibodies to RNA polymerase III in systemic sclerosis. Clin Exp Rheumatol 2007, 25:373-377.
34. Shapira Y., Agmon-Levin N., Shoenfeld Y. Geoepidemiology of autoimmune rheumatic diseases. Nat Rev Rheumatol 2010, 6:468-476.
35. Caramaschi P., Biasi D., Volpe A., Carletto A., Cecchetto M., Bambara L.M. Coexistence of systemic sclerosis with other autoimmune diseases. Rheumatol Int 2007, 27:407-410.
36. Tanaka A., Igarashi M., Kakinuma M., Oh-i T., Koga M., Okuda T. The occurrence of various collagen diseases in one family: a sister with LSSc, PBC, APS, and SS and a brother with systemic lupus erythematosus. J Dermatol 2001, 28:547-553.
37. Mellemkjaer L., Pfeiffer R.M., Engels E.A., Gridley G., Wheeler W., Hemminki K., et al. Autoimmune disease in individuals and close family members and susceptibility to non-Hodgkin's lymphoma. Arthritis Rheum 2008, 58(3):657-666.
38. Pakozdi A., Nihtyanova S., Moinzadeh P., Ong V.H., Black C.M., Denton C.P. Clinical and serological hallmarks of systemic sclerosis overlap syndromes. J Rheumatol 2011, 38:2406-2409.
39. Koumakis E., Dieude P., Avouac J., Kahan A., Allanore Y. Association des Sclérodermiques de France. Familial autoimmunity in systemic sclerosis - results of a French-based case-control family study. J Rheumatol 2012, 39:532-538.
40. Agarwal S.K., Tan F.K., Arnett F.C. Genetics and genomic studies in scleroderma (systemic sclerosis). Rheum Dis Clin N Am 2008, 34:17-40.
41. Zimmermann A.F., Pizzichini M.M.M. Atualização na etiopatogênese da esclerose sistêmica. Rev Bras Reumatol 2013, 53(6):516-524.
42. Anaya J.M., Tobon G.J., Vega P., Castiblanco J. Autoimmune disease aggregation in families with primary Sjögren's syndrome. J Rheumatol 2006, 33:2227-2234.
43. Jawaheer D., Seldin M.F., Amos C.I., Chen W.V., Shigeta R., Monteiro J., et al. A genomewide screen in multiplex rheumatoid arthritis families suggests genetic overlap with other autoimmune diseases. Am J Hum Genet 2001, 68:927-936.
44. McGregor A.R., Watson A., Yunis E. Familial clustering of scleroderma spectrum disease. Am J Med 1988, 84(6):1023-1032.
45. Arnett F.C., Cho M., Chatterjee S. Familial occurrence frequencies and relative risks for systemic sclerosis (scleroderma) in three United States cohorts. Arthritis Rheum 2001, 44(6):1359-1362.
46. Baldini C., Mosca M., Della Rossa A., Pepe P., Notarstefano C., Ferro F., et al. Overlap of ACA-positive systemic sclerosis and Sjögren's syndrome: a distinct clinical entity with mild organ involvement but at high risk of lymphoma. Clin Exp Rheumatol 2013, 31:272-280.
47. Nakamura T., Higashi S., Tomoda K., Tsukano M., Sugi K. Primary biliary cirrhosis (PBC)-CREST overlap syndrome with coexistence of Sjögren's syndrome and thyroid dysfunction. Clin Rheumatol 2007, 26:596-600.
48. Balbir-Gurman A., Braun-Moscovici Y. Scleroderma overlap syndrome. IMAJ 2011, 13:14-20.
49. Costa C.C.B., Medeiros M., Watanabe K., Martin P., Skare T.L. Tireoidite de Hashimoto pode estar associada a um subgrupo de pacientes de esclerose sistêmica com hipertensão pulmonary. Rev Bras Reumatol 2014, 54(5):366-370.
50. Avouac J., Airò P., Dieude P., Caramaschi P., Tiev K., Diot E., et al. Associated autoimmune diseases in systemic sclerosis define a subset of patients with milder disease: results from two large cohorts of European caucasian patients. J Rheumatol 2010, 37:608-614.